MDR-TB GLOBALLY AND IN THE REGION 2013 Dr Samiha Baghdadi Medical officer – STB WHO – EMRO Cairo March 2014.

Slides:



Advertisements
Similar presentations
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Advertisements

DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
CURRENT SITUATION OF E-HEALTH IN MYANMAR Nang Kham Oo Leik Central Womens Hospital
0 - 0.
Addition Facts
A Roadmap to Successful Implementation Management Plans.
Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Thematic evaluation on the contribution of UN Women to increasing women’s leadership and participation in Peace and Security and in Humanitarian Response.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Improving diagnosis TB laboratory strengthening.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
PPM SUBGROUP MEETING Cairo, 3-5 June 2008 Involving all health care providers in the MDR and XDR-TB response Matteo Zignol Stop TB Department World Health.
MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5.
Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.
Country Update: Tuberculosis in Thailand
Overview of strategy for FY 14 Myanmar. CAP-TB: Goal To reduce the incidence and mortality from MDR TB in Myanmar In partnership with National Tuberculosis.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Addition 1’s to 20.
Test B, 100 Subtraction Facts
Multidrug- resistant tuberculosis: update Multidrug-resistant TB in the world update October 2012  WHO 2012 © World Health Organization 2012.
Dr. Samiha Baghdadi – Medical officer EMRO –STB ICIUM - Antalya November 2011.
World TB Day 2011 March 24, 2011 Mavuso Centre Manzini – Kingdom of Swaziland.
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Building the Foundations for Better Health Health Services Organization.
Workshop objectives and agenda Dr. Samiha Baghdadi MO-STB WHO-EMRO Cairo June 2008.
The Global Plan to Stop TB, (1)
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
RNTCP: DOTS Expansion and plans for DOTS-Plus
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
WHO-CEHA Inter-Water Thesaurus and other WHO Sources for Health and Environment Terminology Mazen Malkawi Technical Information Officer WHO/EMRO/CEHA.
Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
There is no single epidemic in the Middle East and North Africa – learning from facts to shape the AIDS response UNAIDS Secretariat, the World Bank and.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
TB, MDR-TB and XDR-TB in South Africa October 2006.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
TB infection control and prevention of XDR Group II.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Introduction of outpatient care for DS-/MDR-TB patients in Tajikistan Cape Town, December 02-06, 2015.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
Ebola preparedness and Response in Lao PDR. Outline Objective The preparedness contingency plan Phase 1: Preparedness Phase 2: Contingency for response.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Current Aspects of TB in Egypt and other EMR countries Dr. Essam Elmoghazy Chairman of Cairo Association against Smoking, Tuberculosis and Lung diseases-
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Progress and plans for PPM in the Eastern Mediterranean Region Fifth PPM Subgroup Meeting June, Cairo.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Journey For Scaling up Family Practice
Achieving WHO Recommendations for HCV Elimination in the Eastern Mediterranean Region I. Waked April 12, 2016.
World Tuberculosis Day 2014
World Tuberculosis Day 2014
World Tuberculosis Day 2015
Tuberculosis situation in the EU/EEA, 2016
Key issues in DOTS implementation
World Tuberculosis Day 2014
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Health system assessments
5th DEWG meeting Conclusions
Presentation transcript:

MDR-TB GLOBALLY AND IN THE REGION 2013 Dr Samiha Baghdadi Medical officer – STB WHO – EMRO Cairo March 2014

The structure of the presentation • MDR-TB burden globally and in the region • MDR-TB notification • MDR – TB treatment outcomes • Regional challenges and strategic directions • Ambulatory care for MDR-TB

Global coverage of data on DR-TB

MDR-TB rate among New TB cases

MDR-TB rate among previously treated TB cases

Estimated MDR-TB among TB cases by WHO region

Contribution of WHO regions to MDR-TB burden 2012

Countries notified at least 1 XDR case

MDR-TB cases 2012 Estimated, notified and enrolled on treatment

Estimated Number of MDR-TB cases among notified TB cases 2012

Confirmed MDR-TB cases among notified TB cases 2012

Contribution to MDR-TB notification by region 2012

Treatment outcomes

Treatment success rate by country 2011

Regional challenges/risks foreseen • Unstable situation in many countries in the region, namely (Afghanistan, Egypt, Lebanon, Iraq, Pakistan, Somalia, Syria, Tunisia and Yemen). This situation resulted in several challenges as follows: • Huge population movement across the region • Huge staff turn over • Destruction of infrastructure • Limited movement in the field • Sever loss of drugs and equipment • Limited lab capacity • Culture and DST are not available in Somalia and South Sudan. DST is not available in Afghanistan. • Most of the countries in the region did not widely apply the new diagnostics. • DR survey and surveillance: • Updated survey is ongoing in Iraq, Iran, Pakistan, Sudan, and needed in Syria. • There is a need to document/report results of DR surveillance that is ongoing in GCC countries, and expand the continuous surveillance in the remaining 15 countries. • Libya is still the only country in the region without proper management of MDR-TB management.

Regional challenges/risks foreseen • Expected financial gap to support scaling up MDR-TB activities in most countries, mainly (Djibouti, Egypt, Lebanon, Jordan, Iran, Pakistan and Syria). • Limited human resources at country level (MDR local support on continuous basis is needed in Afghanistan, Iraq, Pakistan and Sudan mainly). • Limited consultancy capacity in the region in general ( a team of 5 consultants was established last year to support countries)

The strategic directions of the work of EMR_GLC • Improve planning for PMDT (update the regional plan and support planning at country level), • Develop regional high standard ambulatory based model • Develop Regional framework and guidance about the utilization of New diagnostics and lab support, • Scale up R&R for MDR, infection control at all levels, HR capacity, • Promote prequalified regional companies; develop mechanisms for joint proposals, drugs grants. • Operational research

Promote using ambulatory model in MDR- TB care Justification: • Limited country capacity (infrastructure: hospitals, infection control) and financial. • New diagnostics increase case detection (X-Pert). • Long waiting list of detected cases. • Global experience is encouraging However : Ambulatory care does not exclude hospitalization

What do we need for ambulatory model • Networking: • Diagnosis, • Treatment, • Treatment follow up, • Side effect management, • Daily observation and care, • Social support

Some basic items for provincial profile 1. Population 2. Admin areas 3. Geographical description 4. Notified cases/notification rate ( TB type, Age and gender) 5. Treatment outcomes ( TB type, Age and gender) 6. Estimated MDR-TB cases among new and previously treated 7. Infection control 8. Lab coverage 9. EQA for DSM 10. C/DST coverage 11. PPM coverage 12. PHC coverage 13. Hospitals available 14. Referral system 15. Community support 16. Provincial map (PHC facilities, hospitals, laboratories, TB facilities, PPM facilities, patient distribution, MDR cases distribution) and community support points. 17. Security issues 18. MDR focal person

RO support to countries for AT • Briefing about ambulatory model 2012 • Training on planning 2013 • Follow up planning process 2013 Future plans 2014 • Monitoring missions and evaluation • Lesson learnt

SWOT analysis

Stakeholder analysis/matrix

Provincial profile

Provincial map

Strategic frame work

OP plans